Health

Health
How the White House got 2 pharma rivals to work together on a COVID-19 vaccine
A 15-minute call with Johnson & Johnson executives on a Sunday afternoon stretched into a 75-minute turning point. "We have to take bold action and overwhelm this," a senior official said.
March 3 update on COVID-19 in MN: Vaccinations quicken; Walz upbeat about State Fair
Activities set for “June and beyond, those look pretty promising,” an upbeat Gov. Tim Walz told reporters Wednesday. His remarks came hours after state data shows the vaccination trend line at a new high, while active COVID-19 cases and hospitalizations hold fairly steady.
Drug overdose deaths surge among Black Americans during pandemic
Black Americans with addiction face "pervasive and continuing systemic racism" and often struggle to gain access to treatments that prevent fatal overdoses.
Worried about coronavirus variants? Here's what you need to know
Scientists are spotting new coronavirus variants almost on a daily basis. So far public health experts are still most worried about three important ones.
New center to reframe how we research health disparities
A new grant from Blue Cross and Blue Shield of Minnesota will support antiracism research in the School of Public Health at the University of Minnesota.
As virus-era attacks on Asians rise, past victims look back
Asian Americans have faced a dangerous climate since the coronavirus entered the U.S. a year ago. Now, just over a year and thousands of incidents later, some of the earliest victims find moving forward has been difficult or, at best, bittersweet. 
How can we stop the surge in addiction and overdose deaths?
Host Angela Davis speaks to an addiction doctor and two young people in recovery about why substance use and overdoses rose during the pandemic and what we can do about it. 
Biden vows enough vaccine for all U.S. adults by end of May
President Joe Biden says the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated, as his administration announced that drugmaker Merck & Co. will help produce Johnson & Johnson’s newly approved shot.